Investors
Invest in the future of nutrition and sustainable agriculture
A scalable platform integrating biotechnology, advanced nutrition and sustainability, with six proprietary technologies and international licensing potential.
Investors
The opportunity
The global market demands more efficient, sustainable and regenerative solutions. INTEGRA NEXUS turns raw materials and agro-industrial waste into high-value functional products, with proprietary technology and scientific backing.
- Six biotech technologies in development, from R&D to scale-up
- A replicable model: product + licensing + recurring royalties
- Aligned with global trends in health, sustainable food and the circular economy
Market
Investors
Business model
We diversify revenue across product sales, licensing and services.
Direct sales of premium ingredients and fertilizers
Large-scale supply to agribusiness and cooperatives
Technology licensing and know-how transfer
Recurring royalties for use of the technology
Deployment of modular plants
Joint product development under NDA
How we work
Roadmap
Research & development
Development of proprietary technologies and scientific validation.
Pilot plant
Process optimization, scale-up and functionality testing.
Industrial production
Large-scale manufacturing with traceability and quality control.
International licensing
Technology transfer and global expansion.
Use of funds
Capital goes to taking the technologies from the lab to the market.
- Building and operating a pilot plant
- Industrial validation and process optimization
- Intellectual-property protection
- National and international commercial expansion
- Strengthening the technical and commercial team
Investors
Investment dossier
Detailed material —projections, structure and terms— is shared privately with qualified investors, on request and after signing a confidentiality agreement.
Prefer to write to us directly? sales@integranexus.net
Frequently asked questions
What stage is the project at?
The technologies are between R&D and pilot-plant scale-up, with trials and validations in progress depending on the project.
What are you looking for from an investor?
Capital for scale-up and, in some cases, strategic partners for commercial validation and international expansion.
How is the technology protected?
Through proprietary know-how, differentiated formulations and intellectual-property processes in progress.
Is the investment in one technology or in the platform?
Both are possible; we define it according to the investor's interest and profile.
How do I access the figures?
Request the dossier using the form on this page; after we review your profile and sign the NDA, we share the full material.